The last of the non-core assets was divested in July.
Q2 EBITA EUR 2.5m (ABGSCe EUR 6.9m) We cut '25e-'27e adj.
Report out 22 August '25e-'26e sales cut by 19-15% on lower expected machine deliveries 3y deal sign...
Q2 pre-tax profit came in at DKK 115m, DKK 19m (20%) above our estimate.
Redeye comments on Freemelt’s Q2 results, which marked a record quarter for the company, with revenu...
Q2 sales on par with FY'24, below ABGSCe only on delivery timings Deliveries likely pushed into H2, ...
North American weakness behind yesterday's Q2 PW FY guidance cut more than feared Estimates likely d...
Den tekniska utvärderingen av Prostatypes gentest fortsätter för att få produkten inkluderad i det a...
Ahead of Relais' Q2 results, we incorporate its latest acquisitions into our estimates and adjust fo...
We lower adjusted EBIT by 13% for 2025E and 6% for 2026E-27E.
Redeye views BeammWave’s rights issue of up to SEK65m as a positive and necessary step to expedite i...
Q2e: Clean paper EBIT of ~PLN 10m Challenging markets Fair value range of SEK 25-70 Q2e Paper EBIT ...
Ahead of Suominen's Q2 report, we maintain our estimates intact.
Redeye comments on last week's news where Google lost its antitrust appeal related to its app store ...
Suominen reports Q2 results on Aug 7. We believe H1’25 earnings will remain rather flat, but H2 shou...
Delays weigh down the quarter’s results.
Solwers’ Board of Directors has today appointed Johan Ehrnrooth as Solwers’ upcoming CEO and he will...
Cancom Q2 PW and cut FY'25 EBITA guidance by -25%, stock -8% Blames reluctant customers, and particu...
Redeye comments on GiG’s preliminary Q2-results which were in line with our forecasts and the announ...
Redeye comments on the partnership with SD Pharma in Spain, which will broaden physician reach of Pe...
